Cover Image
Market Research Report

Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021

Published by TechNavio (Infiniti Research Ltd.) Product code 563469
Published Content info 74 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021
Published: October 4, 2017 Content info: 74 Pages
Description

About Circulating Tumor Cell (CTC) Diagnostics

Cancer is diagnosed by blood count, bone marrow biopsy, and molecular identification of mutated cells. CTC diagnostics helps in the identification of deoxyribonucleic acid (DNA) shed by tumor cells. CTCs are cancerous cells which detach from primary tumor and migrate in the bloodstream or lymphatic system of the patient. CTCs in the blood or lymphatic system helps in providing important information regarding prognosis and treatment effectiveness for cancer patients.

Technavio's analysts forecast the global circulating tumor cell (CTC) diagnostics market to grow at a CAGR of 9.39% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global circulating tumor cell (CTC) diagnostics market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • ApoCell
  • Qiagen
  • Menarini Silicon Biosystems

Other Prominent Vendors

  • Advanced Cell Diagnostics
  • BioCep
  • BIOCEPT
  • BioFluidica
  • Celltraffix
  • Clearbridge Biomedics
  • Creatv MicroTech
  • Cynvenio
  • Epic Sciences
  • Fluxion Biosciences
  • Gilupi
  • Ikonisys
  • IVDiagnostics
  • ScreenCell

Market driver

  • Increasing incidences of cancer
  • For a full, detailed list, view our report

Market challenge

  • High cost of diagnostics
  • For a full, detailed list, view our report

Market trend

  • Introduction of advanced detection technologies
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR14888

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by end-user

  • Market overview

PART 07: Geographical segmentation

  • Overview
  • Americas
  • EMEA
  • APAC

PART 08: Decision framework

PART 09: Drivers and challenges

  • Market drivers
  • Market challenges

PART 10: Market trends

  • Introduction of advanced detection technologies
  • Application of CTC as biomarkers for drug discovery

PART 11: Vendor landscape

  • Competitive scenario

PART 12: Key vendor analysis

  • ApoCell
  • Menarini Silicon Biosystems
  • Qiagen
  • Other prominent vendors

PART 13: Appendix

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global CTC diagnostics market 2016-2021: Overview
  • Exhibit 02: Global CTC diagnostics market 2016-2021 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global CTC diagnostics market by end-user 2016-2021: Overview
  • Exhibit 05: Global CTC diagnostics market segmentation by end-user 2016
  • Exhibit 06: Impact assessment of global CTC diagnostics market 2016-2021
  • Exhibit 07: Buying criteria for end-users in global CTC diagnostics market 2016
  • Exhibit 08: Global CTC diagnostics market by geography 2016-2021: Overview
  • Exhibit 09: CTC diagnostics market in Americas 2016-2021: Overview
  • Exhibit 10: CTC diagnostics market in Americas 2016-2021 ($ billions)
  • Exhibit 11: Americas: Market metrics in various countries
  • Exhibit 12: CTC diagnostics market in Americas: Future outlook
  • Exhibit 13: CTC diagnostics market in EMEA 2016-2021: Overview
  • Exhibit 14: CTC diagnostics market in EMEA 2016-2021 ($ billions)
  • Exhibit 15: EMEA: Market metrics in various countries
  • Exhibit 16: CTC diagnostics market in EMEA: Future outlook
  • Exhibit 17: CTC diagnostics market in APAC 2016-2021: Overview
  • Exhibit 18: CTC diagnostics market in APAC 2016-2021 ($ billions)
  • Exhibit 19: APAC: Market metrics in various countries
  • Exhibit 20: CTC diagnostics market in APAC: Future outlook
  • Exhibit 21: Breast cancer statistics in various countries
  • Exhibit 22: Competitive structure analysis of global CTC diagnostics market 2016
  • Exhibit 23: Competitive landscape analysis of global CTC diagnostics market 2016
  • Exhibit 24: Strategic success factors of companies in global CTC diagnostics market 2016
  • Exhibit 25: ApoCell: Key highlight
  • Exhibit 26: ApoCell: Strength assessment
  • Exhibit 27: ApoCell: Strategy assessment
  • Exhibit 28: ApoCell: Opportunity assessment
  • Exhibit 29: Menarini Silicon Biosystems: Key highlights
  • Exhibit 30: Menarini Silicon Biosystems: Strength assessment
  • Exhibit 31: Menarini Silicon Biosystems: Strategy assessment
  • Exhibit 32: Menarini Silicon Biosystems: Opportunity assessment
  • Exhibit 33: Qiagen: Key highlights
  • Exhibit 34: Qiagen: Strength assessment
  • Exhibit 35: Qiagen: Strategy assessment
  • Exhibit 36: Qiagen: Opportunity assessment
  • Exhibit 37: Other prominent vendors
Back to Top